Clinical Trials Browser

Unknown × Advanced Refractory Solid Tumors × Clear all

NCT04892498 2022-08-09

Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)

Phase 2 Unknown

Other solid neoplasm

Advanced Refractory Solid Tumors

NCT02300467 2015-08-14

NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Refractory Solid Tumors